NCT01091532
- Conditions
- Multiple Dose, Pharmacokinetic, Phase 1, +2 more
- Locations
-
- Pfizer Investigational Site Brussels, Belgium
Clinical trial condition
Explore clinical trials studying Safety. Study availability and eligibility vary by location and protocol.
NCT01091532
NCT02512575
NCT03655522
Not specified
NCT01954589
NCT03033329
Not specified
NCT02479412
NCT01789528
NCT01193335
NCT02484729
NCT03120091